Boundless Bio - BOLD Company Short-Term Debt

Graphic logo of boundlessbio.com (BOLD)

Short-term financial liabilities reflect obligations with a maturity of up to one year, where the 0.00 indicator expresses the state of the metric. Geopolitical fragmentation is currently hindering the international exchange of biomaterials and research. Meanwhile, Boundless Bio, Inc. (BOLD) is attracting leading oncologists through generous RSUs and innovative R&D. However, the lack of commercial products leaves the company dependent on venture capital investments to maintain operations.

BOLD (Boundless Bio) Company Short-Term Debts history from 03/29/2024 to 10/28/2026
Manufactured product of Boundless Bio, Inc.

Scaling the Spyglass platform to combat cancer resistance requires intensive funding, which is reflected in the borrowing dynamics of Boundless Bio, Inc. (BOLD). An analysis of total short-term debt captures the volume of obligations maturing within one year, allowing investors to assess the company's liquidity and the efficiency of its liability management while executing its expansion strategy for precision oncology drugs.

Competitor analysis for Boundless Bio, Inc.

TEM - Company Short-Term Debts|QGEN: Company Short-Term Debt|Company Short-Term Debt IONS|Short-Term Debt Repligen Inc.|RNA (Avidity Biosciences) - Company Current Liabilities|Company Short-Term Debts CRSP|Company Short-Term Debt GeneDx WGS|Company Short-Term Indebtedness Ultragenyx Pharmaceutical Inc. (RARE)|BEAM - Company Short-Term Debts|Sarepta Corp - Company Short-Term Indebtedness|TWST - Company Short-Term Debt|TXG - Company Short-Term Debt|Company Short-Term Debts NTLA|STOK (Stoke Therapeutics Inc) - Short-Term Debt|BLFS: Company Short-Term Debt|Short-Term Debt Volume WVE|MAZE (Maze Therapeutics Inc) - Company Short-Term Debt|Short-Term Debt Volume sionnatx.com SION|Company Current Liabilities Prime Medicine|Company Short-Term Loans and Borrowings Taysha Gene Therapies Inc TSHA|QURE - Company Short-Term Debts|MGTX - Company Short-Term Debt|REGENXBIO Inc. - Company Short-Term Debts|SLDB (solidbio.com) - Short-Term Debt Volume|Company Short-Term Debt OCGN (Ocugen)|Short-Term Debt Pacific Biosciences of California, Inc. (PACB)|Benitec (BNTC) - Company Current Liabilities|Company Short-Term Loans and Borrowings Design Corp (DSGN)|Company Short-Term Debts RCKT|4dmoleculartherapeutics.com - Short-Term Debt Volume|Lexeo (LXEO) - Company Short-Term Debt|KRRO - Company Short-Term Indebtedness|EDIT (Editas) - Company Short-Term Debts|Company Current Liabilities Silence Therapeutics Corp|PRQR: Company Current Liabilities|Short-Term Debt Volume Codexis Bio|Company Short-Term Debts Sangamo Therapeutics, Inc. (SGMO)|Company Short-Term Debt NAUT (nautilus.bio)|MGX: Company Short-Term Debt|precisionbiosciences.com - Short-Term Debt|GBIO - Company Short-Term Debt|XCUR - Company Short-Term Debt|Company Short-Term Debts imunon.com|Phio Pharmaceuticals Corp. (PHIO) - Company Short-Term Indebtedness|Company Short-Term Debts Mustang Bio Inc (MBIO)|Company Short-Term Indebtedness RNAZ|Company Short-Term Debt Bionano Genomics, Inc. BNGO|Company Short-Term Indebtedness adnas.com (APDN)|Company Short-Term Debts BLUE (bluebird bio)|Company Short-Term Debts ImmunoPrecise Antibodies Ltd IPA|OMGA - Company Short-Term Debts|OMIC: Company Short-Term Debt|Company Short-Term Debt RGLS|Short-Term Debt syros.com|TBIO (Telesis Bio) - Company Current Liabilities|Company Short-Term Debts TCON|Company Short-Term Debt Unity Bio UBX